Lakeland Financial Corporation operates as the bank holding company for Lake City Bank that provides various banking products and services in the United States.
FAIL · Does not pass the screen
60.09 USD
Price as of 30 Oct 2026Daily close, not a live quote
Screened 2026-10-30 · the tape above runs as of 21:09 UTC · 1 Nov · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.50, read 2026-10-30
Ethical does not pass the values gate
Price60.09 USD
Fair value62.23
Ethical score30.0/100
Our investment reviews on this name
2026-10-26Read Accumulation57.02+5.4% to today ✓Markdown gives way to Accumulation after a 5% slide in 7 weeks
2026-09-04Read Markdown60.07+0.0% to today Accumulation gives way to Markdown with volume flow in agreement
2026-08-04Read Accumulation62.68-4.1% to today Distribution gives way to Accumulation
2026-07-02Read Distribution61.83-2.8% to today ✓First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Lakeland Financial Corporation holds its Markup at $60.09. Consolidating, no directional conviction, held for 445 days.
As held on the ledger · 2026-10-30
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 445 days
Price at the screen
$60.09
Valuation
13.92 trailing · 13.47 forward price to earnings
Values screen
FAIL· score 30.0
Beta
0.76
The Workings
Five Screens, Shown in Full
Does not pass. Prohibited keyword in sector/industry: bank
Test
Figure
Limit
What it means
Status
Business activity
Excluded
Core business clean
Prohibited keyword in sector/industry: bank
Fail
Debt load
Excluded
Below 33%
Interest-bearing debt is of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
Excluded
Below 33%
Interest-bearing cash and securities are of assets, above the one-third limit.
Fail
Receivables
Excluded
Below 49%
Money owed to the company is of assets, above the 49% limit.
Fail
Revenue purity
Excluded
Below 5%
of revenue comes from non-compliant sources, over the 5% line.
Fail
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Lakeland Financial does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.
Read as at 2026-10-31. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when LKFN's ethical verdict changes
Today LKFN does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-30 screen. The gold marker is the market price at the same screen. A 3.6% margin of safety to the base estimate.
Where our models see it going: fair-value estimate $62.23, with a range of $57.60 to $73.09, dated to the 2026-10-30 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Regional Bank Numbers Look Solid But We Pass
Every time a Midwest family opens a checking account or a local firm needs a loan, the cash flows through one of these community banks. Lakeland shows respectable momentum with 19 percent revenue growth, a 41 percent profit margin and 15 percent ROE, yet none of that matters once the ethical screen flags the sector outright.
We are staying away for that single reason. The shares trade at a 14 times forward multiple with only a 6 percent margin of safety to our fair value and analysts sit on a hold rating with a 66 dollar median target. Those details would normally invite closer scrutiny, but the screen exists precisely to remove the entire category from consideration.
Risk sits in the usual cyclical exposure to interest rates and credit cycles that can turn quickly for regional lenders. This is exactly what the screen is for. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
LKFN trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (4 analysts) rates it none, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markdown$57.02+0.0%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (4 analysts) rates it none, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Markdown$57.02+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (4 analysts) rates it none, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Markdown$57.02+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (4 analysts) rates it none, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Markdown$57.02+0.0%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (4 analysts) rates it none, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Markdown$57.02+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (4 analysts) rates it none, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-20Markdown$57.02+0.0%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (4 analysts) rates it none, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-19Markdown$57.02+0.0%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 2% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (4 analysts) rates it none, with a mean price target of $66. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Markdown$57.02-3.1%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (4 analysts) rates it none, with a mean price target of $66.
2026-10-02Markdown$58.85-2.0%Entry 6
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 2.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are up 2%. Our forward projection puts the odds of a 10% gain over the next month near 17%. The street (4 analysts) rates it none, with a mean price target of $66.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
